Polycystic Ovarian Syndrome: Long-Term Health Consequences
- 1 May 2017
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 35 (03) , 271-281
Abstract
Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy in women and can be associated with significant adverse sequelae that can affect overall long-term health and well-being. This review provides a succinct but comprehensive overview of our current understanding concerning the known morbidities of PCOS, beginning with a review of the importance of the different phenotypes of PCOS in determining long-term morbidity, the confounding impact of obesity on health outcomes in PCOS, and the immediate short-term consequences of the disorder (including dermatologic, reproductive, and mood disturbances). The longer-term morbidities of PCOS are then reviewed including metabolic consequences (impaired glucose tolerance and type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease), dyslipidemia and vascular dysfunction (including hypertension and increased incidences of cerebrovascular accidents and thromboembolisms on oral contraceptives), neoplastic (primarily endometrial adenocarcinoma), and mental health disorders (including greater incidences of depressive and anxiety disturbances and psychosexual dysfunction). In conclusion, strategies for the prevention and amelioration of long-term morbidities in PCOS are presented.Keywords
This publication has 90 references indexed in Scilit:
- Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysisCanadian Medical Association Journal, 2012
- Metformin and breast cancer risk: a meta-analysis and critical literature reviewBreast Cancer Research and Treatment, 2012
- Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertility and Sterility, 2012
- Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome SocietyHuman Reproduction Update, 2011
- Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controlsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanBMC Medicine, 2010
- Regulation of Adiponectin Secretion by Adipocytes in the Polycystic Ovary Syndrome: Role of Tumor Necrosis Factor-αThe Journal of Clinical Endocrinology & Metabolism, 2010
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndromeInternational Journal of Gynecology & Obstetrics, 2009
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Polycystic ovary syndrome and risk of uterine leiomyomataFertility and Sterility, 2007